APA (7th ed.) Citation

NM, R., J, S., B, S., D, O., A, N., B, C., & TC, B. (2026). Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease. Ophthalmology and therapy, 15(5), 1807. https://doi.org/10.1007/s40123-026-01379-0

Chicago Style (17th ed.) Citation

NM, Radcliffe, Sheppard J, Simmons B, Owen D, Nguyen A, Cavanagh B, and Brady TC. "Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease." Ophthalmology and Therapy 15, no. 5 (2026): 1807. https://doi.org/10.1007/s40123-026-01379-0.

MLA (9th ed.) Citation

NM, Radcliffe, et al. "Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease." Ophthalmology and Therapy, vol. 15, no. 5, 2026, p. 1807, https://doi.org/10.1007/s40123-026-01379-0.